• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Molecular imaging spoils mystery of listeriosis

Article

With the help of molecular imaging, Stanford University biochemist Jonathan Hardy, Ph.D., has added a new chapter to the mystery of listeriosis, a sometimes fatal bacterial infection linked to unpasteurized cheese.

With the help of molecular imaging, Stanford University biochemist Jonathan Hardy, Ph.D., has added a new chapter to the mystery of listeriosis, a sometimes fatal bacterial infection linked to unpasteurized cheese.

As anyone in France knows, pasteurization ruins the flavor of the 500 varieties of cheese manufactured there. The government accepts as a matter of course that a few French people will die every year after eating cheese infected with Listeria, the bacterial cause of listeriosis. (The USDA requires pasteurization for this reason.)

The Pasteur Institute has studied the bacterium for more than 70 years without definitively identifying which organ serves as its central point of habitation. Using recombinant gene technology, Hardy and colleagues introduced the gene for firefly luciferase into the DNA of the bacterium to allow noninvasive tracking with bioluminescent optical imaging in mice. He reportedly had no trouble persuading the mice to eat the subject of his investigation.

Hardy found that Listeria does its deadly work from the gallbladder, whose toxic bile contents were thought to kill bacteria. He presented the study at the 2005 Society of Molecular Imaging meeting in Cologne, Germany.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.